Picture of Zai Lab logo

ZLAB — Zai Lab News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Zai Lab Says China's NMPA Approved AUGTYROTM (REPOTRECTINIB)

May 13 (Reuters) - Zai Lab Ltd  9688.HK :
    * CHINA'S NMPA APPROVED AUGTYROTM (REPOTRECTINIB) FOR
TREATMENT OF
PATIENTS WITH ROS1-POSITIVE NSCLC

Further company coverage:  9688.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zai Lab

See all news